Fascinating articles covering the respiration sector of the pharma industry, from research to new products and innovations.
Galecto tells Pharmafile about the benefits of inhaled technology to treat idiopathic pulmonary fibrosis
RedX share their thoughts about the current and future treatments for idiopathic pulmonary fibrosis
Pharmafile speaks to Open Orphan: Open Orphan tells Pharmafile about the respiratory disease landscape, as well as how human challenge trials may further understanding of the area
Aptar Pharma discuss how PMDIs continue to change the landscape of asthma and COPD treatment